Chronic liver disease is a growing public health concern, and early diagnosis has the potential to transform patient outcomes and quality of life. But what does an early diagnosis truly mean for patients, families, and caregivers? How does this affect those with comorbidities, and how can patients navigate the challenges, and leverage the benefits of an early diagnosis towards better health?

Join us for an insightful multidisciplinary panel to explore the real impact of early detection with a focus on the potential to empower patients to take control of their health  and support prevention. The panel will also discuss challenges such as health and digital literacy, access to care, and sustainable healthy lifestyle changes, with of course opportunity for audience interaction!

Key Themes: 

•  How patients understand their diagnosis and the role of care providers, patient support groups and online communities.

•  The role of cultural and social determinants in shaping health behaviors

•  Challenges in accessing care and health information

•  The essential role of multidisciplinary teams in guiding patients through diagnosis, treatment, and management

Who should watch?

Patients and their families, patient associations, patient advocates, primary healthcare professionals, nurses, dietitians, gastroenterologists, hepatologists, and anyone interested in learning more about chronic liver disease from a patient’s perspective!

Moderator: 

Alina M. Allen MD, MS, Associate Professor of Medicine , Director MASLD Clinic, Mayo Clinic (USA)

Panelists: 

1. Mark Duman, Patient Engagement Pioneer, Strategic consulting for healthcare and life sciences. Lived experience of MASLD (UK)

2. Dr Helen Jarvis, GP Partner, Clinical Lecturer, UK Liver Alliance early detection lead, Primary care advisor to the British Liver Trust, Chair Lancet global commission on liver disease in primary care (UK)

3. Rogerio Ribeiro, Researcher and Patient Advocate at APDP Diabete (Portugal)